An underground market for unapproved weight-loss medications is propelled by social media fitness personalities and sellers on communication apps, according to recent findings.
Experimental Treatment Gaining Traction Via Social Media
The experimental drug, which remains in research studies, is being advertised by social media influencers for its alleged fat-burning properties. Followers are encouraged to message these profiles directly for source information, while also obtaining discount codes.
Thriving Commerce on Social Networks
Separately, a flourishing trade exists on Telegram, where communities with thousands of members share “before and after” photos, injection guides and claims of rapid British shipping. Vendors market the substance there before directing buyers to other platforms for purchases.
Learning About The Experimental Drug
This medication is an investigational injectable developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could assist patients lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.
Medical Experts Voice Concerns
Nevertheless, physicians and pharmacists have warned that the distribution of what is still an unapproved drug in the UK is a cause for concern and could lead to individuals administering substances of unknown origin.
Some experts stated the popularity for the experimental drug could be linked to the rising cost of licensed weight loss treatments such as Mounjaro.
Regulatory Status and Enforcement
Selling retatrutide on TikTok or Telegram is illegal in the UK, as it is an unapproved medication that cannot be marketed or supplied for human use under the British medical regulations.
Several influencers attempt to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still breach pharmaceutical, marketing, and consumer laws, potentially leading to fines, legal action or imprisonment.
Service Response and Material Removal
According to the social media company, the platform has removed problematic content and prohibited related hashtags and query recommendations. The company stated it was dedicated to keeping the service secure and allocating resources in strengthening enforcement strategies.
Online Marketplace Operations
Research also discovered groups with up to nine thousand participants marketing the experimental drug using Telegram's integrated search feature, which operates like a public directory. Typing “retatrutide” instantly brings up groups with thousands of members, filled with images of weight loss, glowing testimonials and detailed guides for preparing or injecting at home.
Within minutes of joining one community, a seller shared contact information, where most purchases take place. The seller sent an guidebook and guaranteed shipping within 48 hours. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None asked about body mass, medical conditions or past usage.
Product Details and Pricing
Within these communities, messages show black plastic packages with Royal Mail labels, stating to contain new batches. One message read: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at home with purified liquid, or pre-filled pens usually sold at £160 for 20 milligrams. When questioned how much time a injector should last, sellers give conflicting answers ranging from a few weeks to “depends on your body”.
Platform Moderation and Security Measures
A spokesperson for the messaging service stated it actively moderated dangerous material on its service including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are injecting substances they can’t verify. Even if the science behind this drug is sound, these online products may not contain what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at Chemist4U.
A medical professional of Asda Online Doctor connected the increase in interest to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With prices rising, individuals are turning to social media. But counterfeit injections are highly risky. You cannot know what’s inside or whether the environment they were produced in was sterile,” she explained.
Her staff has already encountered individuals harmed by self-injection from unverified sources. “We understand the frustration, but purchasing from Telegram or WhatsApp is gambling with your well-being,” stated the doctor. “These materials could be impure or improperly measured.”
Producer Position
A spokesperson from the pharmaceutical company said the substance was in phase 3 research studies and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they explained, noting that any product “falsely representing itself as a Lilly investigational substance not yet approved … may subject patients to potentially serious health risks”.
